🍀Fujifilm to acquire Irvine Scientific Sales Company and IS Japan, leading companies of cell culture media.

By Pharmaceutical

🍀Fujifilm to acquire Irvine Scientific Sales Company and IS Japan, leading companies of cell culture media.

FUJIFILM Corporation (President: Kenji Sukeno) has announced today that it is acquiring all the outstanding shares* of Irvine Scientific Sales Company, Inc. (ISUS) and IS JAPAN CO.,LTD., (ISJ) leading companies in cell culture media, and signed a stock purchase agreement for about US$800 million today.

Fujifilm Global

http://www.fujifilm.com/news/n180329.html

https://www.bloomberg.co.jp/news/articles/2018-03-29/P6C9EO6JTSE801

More from tokioX :

  1. COVID-19: Japanese authorities postpone approval of Avigan: continued deliberation
  2. Fujifilm accelerates production of its influenza antiviral drug “Avigan® Tablet” for COVID-19.
  3. China’s drug regulator launches nationwide investigation into vaccine producers
  4. 💊Fujifilm accelerates new drug development for diagnostic and therapeutic drugs through the merger of group companies to form FUJIFILM Toyama Chemical Co., Ltd.
  5. 💊Fujifilm Kyowa Kirin Biologics与Mylan合作将Humira®生物仿制药商业化（adalimumab）
  6. 💊Production of Liposome Drugs Utilizing Proprietary Technologies Including Anti-Cancer Agent FF-10832 New Manufacturing Facility to be Built at Toyama Chemical, a Fujifilm Company
  7. 💊Fujifilm acquires equity stake in EdiGene, a drug discovery startup.